Regen BioPharma filed an Investigational New Drug application for HemaXellerate I in February 2013 seeking permission from the FDA to initiate a ten patient clinical trial.
http://www.marketwired.com/press-release/bio-matrix-scientific-groups-subsidiary-regen-biopharma-enters-into-preclinical-trials-otcqb-bmsn-1835001.htm
http://www.marketwired.com/press-release/bio-matrix-scientific-groups-subsidiary-regen-biopharma-enters-into-preclinical-trials-otcqb-bmsn-1835001.htm
No comments:
Post a Comment